MAGNEVIST- gadopentetate dimeglumine injection USA - engelska - NLM (National Library of Medicine)

magnevist- gadopentetate dimeglumine injection

bayer healthcare pharmaceuticals inc. - gadopentetate dimeglumine (unii: rh248g8v27) (gadopentetate - unii:v7ok6j19hq) - magnevist injection is indicated for use with magnetic resonance imaging (mri) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. magnevist injection has been shown to facilitate visualization of intracranial lesions including but not limited to tumors. magnevist injection is indicated for use with mri in adults and pediatric patients (2 years of age and older) to facilitate the visualization of lesions with abnormal vascularity in the head and neck. magnevist injection is indicated for use in mri in adults and pediatric patients (2 years of age and older) to facilitate the visualization of lesions with abnormal vascularity in the body. magnevist is contraindicated in patients with: gbcas cross the placenta and result in fetal exposure and gadolinium retention. the human data on the association between gbcas and adverse fetal outcomes are limited and inconclusive (see data). in animal

OMNISCAN 0,5 mmoli/ml Rumänien - rumänska - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

omniscan 0,5 mmoli/ml

ge healthcare as - gadodiamidum - sol. inj. - 0,5mmoli/ml - medii de contrast pentru irm medii de contrast paramagnetice

OMNISCAN Litauen - litauiska - SMCA (Valstybinė vaistų kontrolės tarnyba)

omniscan

ge healthcare as - gadodiamidas - injekcinis tirpalas - 0,5 mmol/ml - gadodiamide

Omniscan 0,5 mmol/ml Injektionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

omniscan 0,5 mmol/ml injektionsvätska, lösning

ge healthcare as - gadodiamid - injektionsvätska, lösning - 0,5 mmol/ml - gadodiamid 287 mg aktiv substans - gadodiamid

Omniscan 0,5 mmol/ml Injektionsvätska, lösning i förfylld spruta Sverige - svenska - Läkemedelsverket (Medical Products Agency)

omniscan 0,5 mmol/ml injektionsvätska, lösning i förfylld spruta

ge healthcare as - gadodiamid - injektionsvätska, lösning i förfylld spruta - 0,5 mmol/ml - gadodiamid 287 mg aktiv substans - gadodiamid

OMNISCAN süstelahus Estland - estniska - Ravimiamet

omniscan süstelahus

ge healthcare as - gadodiamiid - süstelahus - 0,5mmol 1ml 100ml 10tk; 0,5mmol 1ml 20ml 10tk

OMNISCAN Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

omniscan

ge healthcare s.r.l. - gadodiamide - gadodiamide

Omniscan 0,5 mmol/ml Roztwór do wstrzykiwań Polen - polska - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

omniscan 0,5 mmol/ml roztwór do wstrzykiwań

ge healthcare as - gadodiamidum - roztwór do wstrzykiwań - 0,5 mmol/ml

OMNISCAN 0,5 mmol/ml raztopina za injiciranje Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

omniscan 0,5 mmol/ml raztopina za injiciranje

ge healthcare as - gadodiamid - raztopina za injiciranje - gadodiamid 287 mg / 1 ml - gadodiamid

OMNISCAN 0,5 mmol/ml raztopina za injiciranje Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

omniscan 0,5 mmol/ml raztopina za injiciranje

ge healthcare as - gadodiamid - raztopina za injiciranje - gadodiamid 287 mg / 1 ml - gadodiamid